01.17.24 -- A Closer Look At Precision Medicine Clinical Trials

From exploring decentralized trial elements to making operations carbon-negative, the clinical research industry is aligning its goals with broader global sustainability initiatives. 

While biomarkers have improved trial efficiency in some cases, patient-centered clinical outcome assessments remain essential — the lack of which can lead to commercial catastrophe.

Take notes from this multidimensional customer success model to enhance your readiness to address a diverse array of customer requirements and needs effectively.

As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when labeling them for clinical trial distribution.

Overcome challenges and complexities in ophthalmic drug development by partnering with an integrated CRO/CDMO provider with extensive regulatory knowledge and scientific expertise.

Gain insight into why vigorous analytical validation and testing should take place before regulatory submissions so that a companion diagnostic can be delivered as an approved tool for patient care.

See why Marken Monarch is described as the most advanced, efficient, and sustainable passive solution for transporting and safeguarding the supplies of temperature-sensitive pharmaceuticals.

Uncover the compelling advantages DCTs provide, including improved access to diverse populations, consistent information collection, and positive impacts on recruitment, retention, and timelines.

Explore this prebuilt vaccine trial solution that delivers quality and predictability for your entire immunology portfolio to help bring new therapies in historically challenging therapeutic areas.